Interferon-inducible MyD88 protein inhibits hepatitis B virus replication. 2004

Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
Key Laboratory of Medical Molecular Virology, Ministry of Education and Health, Shanghai Medical College, Fudan University, Shanghai 200032, China.

Myeloid differential primary response protein (MyD88) is a critical component in the signaling cascade through Toll-like receptors (TLRs) and is induced by alpha interferon (IFN-alpha). To examine the role of MyD88 in the antiviral activity of IFN-alpha against hepatitis B virus (HBV), we established MyD88 stably expressing cell lines and studied HBV replication in these lines after transient transfection. The levels of HBV proteins and viral replicative intermediates were effectively reduced in MyD88-expressing cells. A significant reduction of total and cytoplasmic viral RNAs in MyD88 stably expressing cells was also observed. Using a nuclear factor-kappaB (NF-kappaB) dependent reporter assay, it was shown that activation of NF-kappaB was moderately increased in the presence of expression of MyD88, and further significantly increased by co-expression of HBV. These results suggest a novel mechanism for the inhibition of HBV replication by IFN-alpha via expression of MyD88 protein involving activation of NF-kappaB signaling pathway and downregulation of viral transcription.

UI MeSH Term Description Entries
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins
D053594 Myeloid Differentiation Factor 88 An intracellular signaling adaptor protein that plays a role in TOLL-LIKE RECEPTOR and INTERLEUKIN 1 RECEPTORS signal transduction. It forms a signaling complex with the activated cell surface receptors and members of the IRAK KINASES. MyD88 Protein,TLR Signal Adaptor Protein MyD88,Toll-Like Receptor Signal Adaptor Protein MyD88,Toll Like Receptor Signal Adaptor Protein MyD88

Related Publications

Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
September 2015, Journal of virology,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
March 2001, Journal of virology,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
December 2007, The Journal of general virology,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
March 2005, Journal of virology,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
January 2015, La Clinica terapeutica,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
December 2014, Scientific reports,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
April 2015, International immunopharmacology,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
October 2011, Journal of biochemistry,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
January 2021, Frontiers in microbiology,
Wei Xiong, and Xun Wang, and Xiaoying Liu, and Li Xiang, and Lingjie Zheng, and Zhenghong Yuan
August 1992, Antiviral research,
Copied contents to your clipboard!